SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001839882-23-030328
Filing Date
2023-11-09
Accepted
2023-11-09 16:27:33
Documents
91
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp_10q-093023.htm   iXBRL 10-Q 1217228
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 10654
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 10761
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER ex32-01.htm EX-32.01 5955
  Complete submission text file 0001839882-23-030328.txt   7194568

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tnxp-20230930.xsd EX-101.SCH 69050
6 XBRL CALCULATION FILE tnxp-20230930_cal.xml EX-101.CAL 77475
7 XBRL DEFINITION FILE tnxp-20230930_def.xml EX-101.DEF 271118
8 XBRL LABEL FILE tnxp-20230930_lab.xml EX-101.LAB 469880
9 XBRL PRESENTATION FILE tnxp-20230930_pre.xml EX-101.PRE 387452
85 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_10q-093023_htm.xml XML 1103661
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 231392998
SIC: 2834 Pharmaceutical Preparations